# QIAGEN expands Germantown, Maryland manufacturing facility for COVID-19 testing

QIAGEN North American Holdings is expanding its US headquarters and R&D manufacturing facility in Germantown, Maryland, renovating its 146,000-square foot facility to expand production of COVID-19 and other disease testing products. The company has already added around 80 contracted staff and invested over $7 million.

- Type: Expansion
- Announced: 2020-12-11
- Where: Germantown, Maryland, United States
- Value: $7.00M
- Jobs: 80
- Status: under construction
- Capacity: 146,000 square feet (manufacturing facility)
- Products: COVID-19 testing products, reagent kits
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Qiagen](https://endata.com/companies/34370.md)

## Sources

- [business.maryland.gov](https://business.maryland.gov/news/qiagen-continues-growth-maryland/), 2020-12-11: "We are delighted to continue expanding our presence here in Germantown."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.